Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSEA
1251
DELISTED
Landsea Homes
LSEA
| $3.15M | ﹤0.01% |
342,300
-72,332
| -17% | -$768K |
|
1252
Alaska Air
ALK
$4.64B
| $3.14M | ﹤0.01% |
77,776
-403,602
| -84% | -$17.1M |
|
1253
Emergent Biosolutions
EBS
$266M
| $3.14M | ﹤0.01% |
460,311
-591,387
| -56% | -$2.54M |
|
1254
Vera Bradley
VRA
$90.1M
| $3.13M | ﹤0.01% |
500,578
+137,552
| +38% | +$957K |
|
|
SEMR
1255
DELISTED
Semrush
SEMR
| $3.13M | ﹤0.01% |
233,647
-36,144
| -13% | -$501K |
|
1256
Build-A-Bear
BBW
$487M
| $3.11M | ﹤0.01% |
123,245
-31,457
| -20% | -$886K |
|
1257
Lamb Weston
LW
$7.53B
| $3.11M | ﹤0.01% |
37,321
+27,547
| +282% | +$2.35M |
|
|
CHX
1258
DELISTED
ChampionX
CHX
| $3.11M | ﹤0.01% |
93,724
-223,920
| -70% | -$7.64M |
|
1259
Community Health Systems
CYH
$424M
| $3.11M | ﹤0.01% |
925,761
-420,793
| -31% | -$1.42M |
|
1260
AdvanSix
ASIX
$454M
| $3.1M | ﹤0.01% |
135,113
+15,242
| +13% | +$380K |
|
1261
Malibu Boats
MBUU
$579M
| $3.09M | ﹤0.01% |
88,294
+64,297
| +268% | +$2.35M |
|
|
ACH
1262
Accendra Health
ACH
$89.2M
| $3.09M | ﹤0.01% |
228,865
+14,311
| +7% | +$293K |
|
1263
Ardelyx
ARDX
$966M
| $3.09M | ﹤0.01% |
416,353
+246,819
| +146% | +$1.74M |
|
1264
Avery Dennison
AVY
$13.9B
| $3.07M | ﹤0.01% |
14,058
+2,819
| +25% | +$626K |
|
1265
Phibro Animal Health
PAHC
$1.43B
| $3.07M | ﹤0.01% |
183,210
+4,700
| +3% | +$75.5K |
|
|
SRCL
1266
DELISTED
Stericycle Inc
SRCL
| $3.06M | ﹤0.01% |
52,785
-117,690
| -69% | -$6.04M |
|
1267
ProFrac Holding
ACDC
$878M
| $3.04M | ﹤0.01% |
409,754
-27,308
| -6% | -$226K |
|
1268
AMC Global Media
AMCX
$512M
| $3.03M | ﹤0.01% |
313,605
+132,207
| +73% | +$1.74M |
|
1269
Twist Bioscience
TWST
$8.83B
| $3.03M | ﹤0.01% |
61,428
+28,027
| +84% | +$1.14M |
|
1270
Global Net Lease
GNL
$2.13B
| $3.02M | ﹤0.01% |
411,245
+2,603
| +0.6% | +$18.9K |
|
|
SEI
1271
Solaris Energy Infrastructure
SEI
$3.52B
| $3.02M | ﹤0.01% |
351,966
+179,096
| +104% | +$1.57M |
|
|
OPI
1272
DELISTED
Office Properties Income Trust
OPI
| $3.02M | ﹤0.01% |
1,478,700
-203,994
| -12% | -$444K |
|
1273
National Healthcare
NHC
$3.58B
| $3.01M | ﹤0.01% |
27,800
-17,203
| -38% | -$1.68M |
|
|
EVRI
1274
DELISTED
Everi Holdings
EVRI
| $3.01M | ﹤0.01% |
358,563
+18,297
| +5% | +$149K |
|
1275
Primoris Services
PRIM
$4.04B
| $3.01M | ﹤0.01% |
60,326
-59,737
| -50% | -$2.96M |
|
Similar funds
Cliff Asness's Q2 2024 Portfolio in Review
As of Q2 2024, Cliff Asness held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Cliff Asness deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- Cliff Asness's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- Cliff Asness added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- Cliff Asness's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- Cliff Asness fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- Cliff Asness's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- Cliff Asness opened 313 new positions and closed 123 in Q2 2024.
- Cliff Asness's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.